middle.news
How Invion’s $2M Korean Grant Could Transform Oesophageal Cancer Treatment
8:08pm on Friday 30th of January, 2026 AEDT
•
Healthcare
Read Story
How Invion’s $2M Korean Grant Could Transform Oesophageal Cancer Treatment
8:08pm on Friday 30th of January, 2026 AEDT
Key Points
Non-dilutive $2M Korean government grant for oesophageal cancer preclinical studies
Expanded perpetual exclusive global license for Photosoft technology
Collaboration with Taiwan’s Protect Animal Health on companion animal cancer studies
Raised $1.3M through convertible notes with cornerstone investors
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Invion (ASX:IVX)
OPEN ARTICLE